Resurgence of BK virus following Covid-19 in kidney transplant recipients

Christophe Masset,Simon Ville,Franck Halary,Benjamin Gaborit,Celine Bressolette-Bodin,Clément Deltombe,Amaury Dujardin,Lola Jacquemont,Sabine Lebot,Delphine Kervella,Lucille Figueres,Diego Cantarovich,Magali Giral,Maryvonne Hourmant,Gilles Blancho,Claire Garandeau,Aurélie Meurette,Jacques Dantal

DOI: https://doi.org/10.1111/tid.13465

Abstract:Kidney transplant recipients have been supposed vulnerable to severe Covid-19 infection, due to their comorbidities and immunosuppressive therapies. Mild-term complications of Covid-19 are currently unknown, especially in this population. Herein, we report two cases of BKV replication after non-severe SARS-CoV-2 infection. The first case was a 59-year-old man, transplanted 3 months ago, with recent history of slight BKV viremia (3.3 log10 DNA copies/ml). Despite strong reduction of maintenance immunosuppression (interruption of mycophenolic acid and important decrease of calcineurin inhibitors), BKV replication largely increased after Covid-19 and viremia persisted at 4.5 log copy/ml few months later. The second case was a 53-year-old woman, transplanted 15 years ago. She had a recent history of BKV cystitis, which resolved with a decrease of MPA dosage. Few weeks after SARS-CoV-2 infection, she presented recurrence of lower urinary tract symptoms. Our reports highlight that SARS-CoV-2 infection, even without severity, could disrupt immune system and particularly lymphocytes, thus leading to viral replication. Monitoring of viral replications after Covid-19 in kidney transplant recipients could permit to confirm these preliminary observations.